FR3097744B1 - Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme - Google Patents
Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme Download PDFInfo
- Publication number
- FR3097744B1 FR3097744B1 FR1907144A FR1907144A FR3097744B1 FR 3097744 B1 FR3097744 B1 FR 3097744B1 FR 1907144 A FR1907144 A FR 1907144A FR 1907144 A FR1907144 A FR 1907144A FR 3097744 B1 FR3097744 B1 FR 3097744B1
- Authority
- FR
- France
- Prior art keywords
- combination product
- help maintain
- natural defenses
- vitamin
- defenses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000013066 combination product Substances 0.000 title abstract 3
- 229940127555 combination product Drugs 0.000 title abstract 3
- 230000037125 natural defense Effects 0.000 title abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- 244000133098 Echinacea angustifolia Species 0.000 abstract 1
- 241000241413 Propolis Species 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 235000014134 echinacea Nutrition 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229940069949 propolis Drugs 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract 1
- 235000005282 vitamin D3 Nutrition 0.000 abstract 1
- 239000011647 vitamin D3 Substances 0.000 abstract 1
- 229940021056 vitamin d3 Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Insects & Arthropods (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Animal Husbandry (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La présente invention a pour objet un produit de combinaison comprenant à titre de substances actives, au moins de l’échinacée, de la propolis, de la vitamine C et de la vitamine D3 sous forme liquide pour aider au maintien des défenses naturelles de l’organisme. L'invention concerne enfin l'utilisation d'un produit de combinaison tel que précédemment défini pour la prévention et/ou le traitement des pathologies infectieuses, qu’elles soient d’origine virale ou bactérienne.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1907144A FR3097744B1 (fr) | 2019-06-28 | 2019-06-28 | Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme |
| EP20735315.2A EP3989995A1 (fr) | 2019-06-28 | 2020-06-25 | Produit de combinaison pour aider au maintien des défenses naturelles de l'organisme |
| PCT/EP2020/067914 WO2020260506A1 (fr) | 2019-06-28 | 2020-06-25 | Produit de combinaison pour aider au maintien des défenses naturelles de l'organisme |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1907144A FR3097744B1 (fr) | 2019-06-28 | 2019-06-28 | Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme |
| FR1907144 | 2019-06-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR3097744A1 FR3097744A1 (fr) | 2021-01-01 |
| FR3097744B1 true FR3097744B1 (fr) | 2022-11-18 |
Family
ID=69104502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR1907144A Active FR3097744B1 (fr) | 2019-06-28 | 2019-06-28 | Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP3989995A1 (fr) |
| FR (1) | FR3097744B1 (fr) |
| WO (1) | WO2020260506A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3120187B1 (fr) * | 2021-02-26 | 2023-12-01 | Mathieu Angelidis | Composition naturelle répulsive |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020028258A1 (en) * | 2000-05-09 | 2002-03-07 | Pharmanex, Llc | Immunostimulant compositions and associated methods |
| IT1397225B1 (it) * | 2009-12-30 | 2013-01-04 | Nm Tech Nanomaterials And Microdevices Technology Ltd | Composizione battericida e virucida per il cavo orale |
| PL2908833T3 (pl) * | 2012-10-17 | 2017-10-31 | Montero Gida Sanayi Ve Ticaret As | Preparaty zawierające wyciągi ziołowe |
| WO2018136490A1 (fr) * | 2017-01-17 | 2018-07-26 | M. Alphabet 3, Llc | Compositions et procédés pour rhume banal |
| US10149831B1 (en) * | 2017-10-19 | 2018-12-11 | Edward Wick | Pharmaceutical composition for treating bacterial and viral infections |
-
2019
- 2019-06-28 FR FR1907144A patent/FR3097744B1/fr active Active
-
2020
- 2020-06-25 WO PCT/EP2020/067914 patent/WO2020260506A1/fr active Application Filing
- 2020-06-25 EP EP20735315.2A patent/EP3989995A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP3989995A1 (fr) | 2022-05-04 |
| WO2020260506A1 (fr) | 2020-12-30 |
| FR3097744A1 (fr) | 2021-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE84968T1 (de) | Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge. | |
| BR112017014088A2 (pt) | aparelho dentário que fornece superfícies oclusais expostas | |
| UY27940A1 (es) | Formulacion de anticuerpos humanos para el tratamiento de trastornos asociados con tnf-a | |
| MA27334A1 (fr) | Utilisation d'inhibiteurs de l'ikb kinase dans le traitement de la douleur | |
| MEP42808A (en) | Use of flibanserin in the treatment of sexual disorders | |
| RU2011115406A (ru) | Новые пиримидиновые производные и их применение в терапии, а также применение пиримидиновых производных в изготовлении лекарственного средства для предупреждения и/или лечения болезни альцгеймера | |
| AR016798A1 (es) | Uso de una cepa de lactobacillus para la elaboracion de un medicamento | |
| Moller et al. | Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol | |
| MA50406B1 (fr) | Inhibiteurs pyrazole de magl | |
| CL2020000491A1 (es) | Métodos para aumentar y/o estabilizar la función cardiaca en pacientes con enfermedad de fabry. | |
| EA200200207A1 (ru) | Применение антагонистов cgrp и ингибиторов высвобождения cgrp для устранения приливов в период менопаузы | |
| MA57226A1 (fr) | Méthodes de traitement d'une splénomégalie | |
| MA30035B1 (fr) | Utilisation d'un extrait insaponifiable de pulpe vegetale dans le traitement du vieillssement cutane | |
| FR3097744B1 (fr) | Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme | |
| MA39447B1 (fr) | Pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine | |
| FR3097743B1 (fr) | Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme | |
| FR2885491B1 (fr) | Traitement de la secheresse keratinique par des glycerides | |
| MA29145B1 (fr) | Préparations pharmaceutiques pour le traitement de la cellulite | |
| EA202190334A1 (ru) | Фармацевтическая лекарственная форма для перорального введения с модифицированным высвобождением | |
| FR3099698B1 (fr) | Produit de combinaison pour aider au maintien des défenses naturelles de l’organisme et à retrouver la forme | |
| MA39448B1 (fr) | (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical | |
| MA39406A1 (fr) | Promédicament de la 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-d-proline | |
| EA201001000A1 (ru) | Антиоксидантное средство масляный бальзам "ювелакс" | |
| MA46778A1 (fr) | Composition intranasale comprenant de la bétahistine | |
| EP0305277A3 (fr) | Application de l'amino-2 trifluoro-méthoxy-6 benzothiazole pour obtenir un médicament destiné au traitement des troubles du sommeil et de la dépression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLFP | Fee payment |
Year of fee payment: 2 |
|
| PLSC | Publication of the preliminary search report |
Effective date: 20210101 |
|
| PLFP | Fee payment |
Year of fee payment: 3 |
|
| PLFP | Fee payment |
Year of fee payment: 4 |
|
| PLFP | Fee payment |
Year of fee payment: 5 |
|
| PLFP | Fee payment |
Year of fee payment: 6 |